Table 1.
Admission year | Admission month | Age (months) | Gender | Number of Hib vaccine doses | Age (months), 1st dose† | Age (months), 2nd dose† | Age (months, 3rd dose† | Samples obtained | Positive assays | Outcome of hospitalisation |
---|---|---|---|---|---|---|---|---|---|---|
2014 |
Dec |
59 |
Male |
3 |
2 |
3 |
4 |
CSF & Blood |
RT-PCR |
Recovered |
2015 |
Jan |
77 |
Male |
3 |
3 |
5 |
6 |
CSF & Blood |
RT-PCR |
Recovered |
2015 |
Feb |
60 |
Male |
0 |
CSF & Blood |
RT-PCR |
Died |
|||
2015 |
Mar |
60 |
Male |
0 |
CSF & Blood |
RT-PCR |
Died |
|||
2015 |
Mar |
82 |
Male |
3 |
2 |
3 |
5 |
CSF & Blood |
RT-PCR |
Recovered |
2015 |
Mar |
89 |
Female |
0 |
CSF & Blood |
RT-PCR |
Recovered |
|||
2015 |
Mar |
2 |
Female |
1 |
2 |
CSF & Blood |
RT-PCR |
Recovered |
||
2015 |
Apr |
14 |
Male |
3 |
10 |
12 |
12 |
CSF & Blood |
RT-PCR |
Recovered |
2015 |
Apr |
3 |
Male |
2 |
2 |
3 |
CSF & Blood |
RT-PCR |
Recovered |
|
2015 |
Apr |
40 |
Male |
3 |
2 |
3 |
4 |
CSF & Blood |
RT-PCR |
Recovered |
2015 |
Jul |
10 |
Female |
1 |
2 |
CSF & Blood |
Blood & CSF culture, Latex, RT-PCR |
Recovered |
||
2015 |
Jul |
10 |
Male |
3 |
2 |
3 |
4 |
CSF & Blood |
RT-PCR |
Recovered |
2015 |
Jul |
81 |
Female |
0 |
CSF & Blood |
RT-PCR |
Recovered |
|||
2015 |
Aug |
90 |
Female |
1 |
53 |
CSF & Blood |
RT-PCR |
Recovered |
||
2016 |
Mar |
10 |
Female |
0 |
CSF & Blood |
Latex & RT-PCR |
Recovered |
|||
2016 |
Apr |
60 |
Male |
0 |
CSF & Blood |
RT-PCR |
Recovered |
|||
2016 |
Aug |
26 |
Male |
3 |
2 |
3 |
4 |
CSF & Blood |
Blood culture |
Died |
2016 |
Sep |
10 |
Male |
0 |
CSF & Blood |
Latex |
Recovered |
|||
2016 | Sep | 8 | Male | 3 | 2 | 3 | 4 | CSF only | Latex | Recovered |
RT-PCR – real time polymerase chain reaction, CSF – cerebrospinal fluid, Latex – latex agglutination
*Hib was detected in CSF by culture, antigen detection by Latex, or RT-PCR, or in blood by culture. No Hib meningitis cases were detected from January to March 2017.
†Dose of Hib vaccine.